Salmedix Lands $45M C

San Diego-based Salmedix has raised $45M in Series C financing in a round led by HIG Ventures, with new investors including Orbimed Advisors, Easton Hunt Capital Partners, Hunt Ventures, Novo A/S, Quilvest Capital and Clariden Bank joining its existing investors. Salmedix is developing oncology drugs with an initial focus on hematologic cancers. More information »